April 26, 2021

Azzur Group Announces Investment from Baird Capital, Accelerating Growth of Early-Phase Life Science Services Including Azzur Cleanrooms on Demand™

HATBORO, PA, April 26, 2021 – Today, Azzur Group (“Azzur”), one of the nation's fastest-growing life science consultancies, announces an investment from Baird Capital, accelerating the expansion of its professional services to industry, including Azzur Cleanrooms on Demand™.


From Discovery to Delivery™, Azzur Group provides full life-cycle solutions across the GxP spectrum. From its Azzur Cleanrooms on Demand™ facilities to its laboratories, training centers, and consulting offices across the nation, Azzur helps pharma, biotech, and medical device companies start, scale, and sustain their businesses. Azzur’s fastest-growing segment, Azzur Cleanrooms on Demand™, provides early-phase life science companies a hybrid alternative to traditional manufacturing cGMP scale-up challenges. Baird Capital’s investment will accelerate the growth of this novel offering while augmenting core capabilities in advisory, consulting, laboratory, and training services.

Baird Capital makes venture capital, growth equity, and private equity investments in strategically targeted sectors around the world. Having invested in more than 320 companies over its history, Baird Capital partners with entrepreneurs and, leveraging its executive networks, strives to build exceptional companies.

Michael Khavinson, Chief Executive Officer of Azzur, said, “We are thrilled to partner with Baird Capital and look forward to the continuing expansion of Azzur’s footprint across the country in key life sciences markets. We are proud of the work we’ve accomplished in our past decade, and we’re excited for our next phase of growth.”

“Baird Capital has a history of investing in pharma services businesses, and we look forward to bringing our resources, relationships, and experiences to support Azzur’s future growth,” said Brett Tucker, Partner with Baird Capital’s private equity team. “We are excited to partner with Michael and his strong leadership team to help them build on their past successes.”

Baird Capital was advised by Edgemont Partners (financial). Brown Gibbons Lang & Company initiated the transaction and acted as the exclusive financial advisor to Azzur Group. Financial details of the deal were not disclosed. Brett Tucker and Dave Schroeder, Baird Capital Operating Advisor, have joined Azzur’s board of directors as part of the investment deal. Gary Knight, former Global Head of Strategy and Corporate Development at VWR (Avantor) and industry veteran, will also join the Azzur board as an independent director.

For more information on Baird Capital’s investment approach, team members, or portfolio, visit www.BairdCapital.com. For more information about Azzur Group, visit www.Azzur.com.
 
###

About Azzur Group
From Discovery to Delivery™, Azzur Group provides the life science community full life-cycle solutions for all their GxP needs. From Azzur Cleanrooms on Demand™ facilities, to our labs, training centers, and consulting offices across the nation, Azzur Group helps organizations start, scale, and sustain their growing enterprises. With nearly four decades of service to the life science community, we have become a trusted partner to the world’s leading pharmaceutical, biotechnology, medical device, and healthcare companies, as well as their supply chain. For more information about Azzur Group, visit Azzur.com.

About Baird Capital
Baird Capital makes venture capital, growth equity and private equity investments in strategically targeted sectors around the world. Having invested in more than 320 companies over its history, Baird Capital partners with entrepreneurs and, leveraging its executive networks, strives to build exceptional companies. Baird Capital provides operational support to its portfolio companies through teams on the ground in the United States, Europe, and Asia, a proactive portfolio operations team, and a deep network of relationships, which together strive to deliver enhanced shareholder value. Baird Capital is the direct private investment arm of Robert W. Baird & Co. For more information, please visit BairdCapital.com.

About Brown Gibbons Lang & Company
Brown Gibbons Lang & Company (BGL) is a leading independent investment bank and financial advisory firm focused on the global middle market. The firm advises private and public corporations and private equity groups on mergers and acquisitions, capital markets, financial restructurings, valuations and opinions, and other strategic matters. BGL has investment banking offices in Chicago, Cleveland, and Philadelphia, and real estate offices in Chicago, Cleveland, and San Antonio. The firm is also a founding member of Global M&A Partners, enabling BGL to service clients in more than 30 countries around the world. Securities transactions are conducted through Brown, Gibbons, Lang & Company Securities, Inc., an affiliate of Brown Gibbons Lang & Company LLC and a registered broker-dealer and member of FINRA and SIPC. For more information, please visit www.bglco.com.

MEDIA CONTACT:
Azzur Group
Katie Kiley Brown
(610) 573-3893
katie.brown@azzur.com

Baird Capital
Rachel Kern
(414) 298-7250
rkern@rwbaird.com

Life Science Moves FAST

Stay in the know by signing up for our newsletter. We’ll share company successes, industry must-know information, and keep you updated on the latest events you don’t want to miss.